繁 简
  • Home
  • About CRMI
    Company Profile
    Board of Directors
    Corporate Structure
    Milestone
    Awards & Recognitions
  • Our Business
    Business Overview
  • Investor Relations
    Corporate Information
    Announcements & Circulars
    Prospectus
    Financial Reports
    ESG Reports
    Stock Information
    Historical Price
    Presentations
    Corporate Governance
    IR Enquiries
  • Press Releases
  • Contact Us
Press Releases

Press Releases

2018
2017
2016
2015
2014
2013
  • 2018.08.15
    Approval by the Shenzhen Development and Reform Commission for the Establishment of a Shenzhen Tissue Engineering Laboratory by a Subsidiary of CRMI
  • 2018.07.05
    The World’s First Bio-Engineered Cornea “Acornea” Formally Incorporating Into Civic The Medical-Care System In Mainland China
  • 2018.04.03
    Approval of the Re-registration of “ActivSkin” The Tissue Engineered Skin Product of CRMI
  • 2018.03.28
    CRMI Announces Results for the Eight Months ended 31 December 2017 Revenue Increased approximately 41% from y-o-y Aggressively Expands Domestic Industrial Layout 
  • 2018.03.07
    Dr. Shi Weiyun, National People's Congress Deputy, “Acornea” Cornea Transplantation Expert of CRMI Proposed the Acceleration of the Application of New products of Biological Engineering Cornea
  • 2018.01.25
    BLB International Company Limited at a total consideration of HK$36 million Acquire Shares of CRMI
  • 2018.01.16
    CRMI enters into a Strategic Framework Cooperation Agreement with Shanghai Lingang Songjiang High-tech Industrial Development Co., Ltd
  • About CRMI
    Company Profile
    Board of Directors
    Corporate Structure
    Milestone
    Awards & Recognitions
  • Our Business
    Business Overview
  • Investor Relations
    Corporate Information
    Announcements & Circulars
    Prospectus
    Financial Reports
    ESG Reports
    Stock Information
    Historical Price
    Presentations
    Corporate Governance
    IR Enquiries
  • Press Releases
  • Contact Us

© China Regenerative Medicine International Limited. All Rights Reserved.   |  Disclaimer

wisdomir wisdom ir